Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland
- PMID: 2815970
- DOI: 10.1016/0264-410x(89)90199-0
Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland
Abstract
Measles vaccination was performed in the arctic district of Scoresbysund, Greenland in 1968, which had never been exposed to natural measles. More than 90% of the total population was vaccinated and a 94-100% seroconversion was obtained. During a serological survey to examine the immunity status of the vaccinees, it was discovered that a temporary increase in measles antibodies took place in the majority of the population 2-4 years after the vaccination. This was not accompanied by clinically observed measles. Most likely, it was due to an inapparent measles infection in a population considered highly immune after vaccination.
Similar articles
-
Long-term antibody response after measles vaccination in an isolated arctic society in Greenland.Vaccine. 1986 Sep;4(3):173-8. doi: 10.1016/0264-410x(86)90006-x. Vaccine. 1986. PMID: 3532604
-
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.Epidemiol Infect. 2000 Apr;124(2):263-71. doi: 10.1017/s0950268899003222. Epidemiol Infect. 2000. PMID: 10813152 Free PMC article.
-
The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.Int J Epidemiol. 1999 Apr;28(2):341-6. doi: 10.1093/ije/28.2.341. Int J Epidemiol. 1999. PMID: 10342701
-
Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity.Am J Epidemiol. 1999 Dec 1;150(11):1238-49. doi: 10.1093/oxfordjournals.aje.a009951. Am J Epidemiol. 1999. PMID: 10588085
-
An Essay on Measles in the Adult.Med Chir Rev. 1847 Oct 1;6(12):477-482. Med Chir Rev. 1847. PMID: 29919162 Free PMC article. Review. No abstract available.
Cited by
-
Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.J Virol. 1999 Jan;73(1):787-90. doi: 10.1128/JVI.73.1.787-790.1999. J Virol. 1999. PMID: 9847389 Free PMC article.
-
Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention.Clin Infect Dis. 2016 Jan 15;62(2):166-172. doi: 10.1093/cid/civ802. Epub 2015 Sep 9. Clin Infect Dis. 2016. PMID: 26354971 Free PMC article.
-
[Elimination of measles plan in the Valencia community: epidemiological surveillance in 2003].Aten Primaria. 2005 Oct 15;36(6):306-11. doi: 10.1157/13079864. Aten Primaria. 2005. PMID: 16238940 Free PMC article. Spanish.
-
Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.J Epidemiol Community Health. 1999 Mar;53(3):173-8. doi: 10.1136/jech.53.3.173. J Epidemiol Community Health. 1999. PMID: 10396495 Free PMC article.
-
Secondary immune response in a vaccinated population during a large measles epidemic.J Clin Microbiol. 1992 Jul;30(7):1778-82. doi: 10.1128/jcm.30.7.1778-1782.1992. J Clin Microbiol. 1992. PMID: 1629334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical